[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Publications found: 1,864
Sort by:

Germany Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well ... economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

December 2012 585 pages

Italy Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well ... economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

December 2012 570 pages

Japan Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities

US$ 5,360.00

... Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well ... economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

December 2012 590 pages

Spain Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well ... economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

December 2012 565 pages

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023

US$ 2,400.00

... Our work shows you the commercial possibilities. Nine ways Small-Molecule Targeted Cancer Therapies: World Market 2013-2023 helps you To sum up, ... following knowledge on the topic: Forecasted revenues to 2023 for the overall world market - you discover the industry's future prospects Predicted revenues of ...

December 2012 174 pages

The Next Wave In Cancer Treatment - Kinase Inhibitors

US$ 2,500.00

This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several ... currently marketed and late stage development kinase inhibitors for cancer treatment. Revenues for this market segment were generated using ...

December 2012 160 pages

European Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

US$ 14,800.00

... report identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, ... disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. ...

November 2012 820 pages

France Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

This report contains 585 pages, 95 tables and presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2012 585 pages

Germany Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

This report contains 585 pages, 95 tables and presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2012 585 pages

Italy Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

This report contains 570 pages, 83 tables and presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2012 570 pages

Japan Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

US$ 5,360.00

This report contains 590 pages, 95 tables and presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2012 590 pages

Spain Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

This report contains 565 pages, 85 tables and presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2012 565 pages

UK Cancer Diagnostics Market : Innovative Technologies and Emerging Business Opportunities

US$ 4,320.00

This report contains 620 pages, 85 tables and presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

November 2012 620 pages

US Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

US$ 6,960.00

This report contains 620 pages, 103 tables and presents a comprehensive analysis of the US cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

November 2012 620 pages

Innovative CA Tumor Marker Tests Technologies and Emerging Markets

US$ 3,880.00

... and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for ...

November 2012 278 pages

Innovative Cancer Diagnostic Technologies and Emerging Markets

US$ 18,960.00

... market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

November 2012 1200 pages

Analysis of Cancer Diagnostic Technologies And Strategic Profiles of Leading Suppliers

US$ 2,800.00

... as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...

September 2012 185 pages

Analysis of Cancer Diagnostic Testing Instrumentation And Strategic Profiles of Leading Suppliers

US$ 2,800.00

This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for cancer diagnostic testing. The report also presents strategic assessments of current and emerging suppliers of cancer ...

September 2012 119 pages

US Market Changes in the Treatment of Advanced Prostate Cancer

US$ 2,900.00

Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence ...

September 2012 30 pages

US Market Changes in the Treatment of Advanced Melanoma

US$ 2,900.00

... regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. This report identifies market changes based on a comparison of physician practice patterns from 2011 and 2012 and provides actionable data for developing marketing strategies.

September 2012 31 pages

Analysis of Emerging Cancer Diagnostic Tests and Strategic Profile of Leading Suppliers

US$ 2,800.00

... Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or ...

September 2012 286 pages

US Market Changes in the Treatment of Advanced Breast Cancer

US$ 2,900.00

... of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 to determine trends across time and changes in practice patterns in the management of advanced breast cancer.

September 2012 34 pages

US Market Changes in the Treatment of Advanced Lung Cancer

US$ 2,900.00

The purpose of this study is to examine changes in the market for therapeutics used in the treatment of advanced lung cancer by examining longitudinal practice patterns of oncologists. Progressively unfolding patient case scenarios were presented to 152 U.S. oncologists for their responses to open-ended ...

September 2012 39 pages

US Market Changes in the Treatment of Non-Hodgkin's Lymphoma

US$ 2,900.00

... factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 using parallel cases to determine trends across time and changes in practice patterns in the management of non-Hodgkin’s lymphoma.

September 2012 46 pages

Future Horizons in the European Cancer Diagnostics Market--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country

US$ 14,800.00

... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for ...

September 2012 820 pages

Analysis of the World Cancer Diagnostics Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

US$ 2,800.00

... well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative ...

September 2012 104 pages

Future Horizons in the Global Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Country

US$ 22,800.00

Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years Examines trends in the U.S., Europe and Japan Reviews current and emerging tumor markers Analyzes applications of emerging diagnostic technologies Forecasts sales of major ...

August 2012 1200 pages

Future Horizons in the French Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment

US$ 4,320.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

August 2012 585 pages

Future Horizons in the Italian Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment

US$ 4,320.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

August 2012 570 pages

Future Horizons in the German Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment

US$ 4,320.00

... bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in German hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

August 2012 585 pages

Future Horizons in the Japanese Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment

US$ 5,360.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Japanese hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

August 2012 590 pages

Future Horizons in the Spanish Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment

US$ 4,320.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Spanish hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

August 2012 565 pages

Future Horizons in the UK Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment

US$ 4,320.00

Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

August 2012 575 pages

Future Horizons in the US Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment

US$ 6,960.00

Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

August 2012 620 pages

Future Horizons in the Global Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country

US$ 22,800.00

Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years Examines trends in the U.S., Europe and Japan Reviews current and emerging tumor markers Analyzes applications of emerging diagnostic technologies Forecasts sales of major ...

August 2012 1200 pages

Future Horizons in the French Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

US$ 4,320.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

August 2012 585 pages

Future Horizons in the German Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

US$ 4,320.00

... bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in German hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

August 2012 585 pages

Future Horizons in the Italian Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

US$ 4,320.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

August 2012 570 pages

Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

US$ 5,360.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Japanese hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

August 2012 590 pages

Future Horizons in the Spanish Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

US$ 4,320.00

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Spanish hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

August 2012 565 pages

Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

US$ 4,320.00

Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

August 2012 575 pages

Future Horizons in the US Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

US$ 6,960.00

Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

August 2012 620 pages

2012 World Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country

US$ 1,560.00

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains ...

June 2012 11 pages

Cancer Generics Market Analysis

US$ 1,000.00

Across the globe, oncology market, one of the fastest growing segments of pharmaceutical industry, has been expanding on back of rising cancer incidences, and hefty investment by private players. Acco...

May 2012 75 pages

2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 22,800.00

... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...

April 2012 1200 pages

2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 585 pages

2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 585 pages

2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 570 pages

2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 5,360.00

This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

April 2012 590 pages

Filters

Search

Publishers

4
3
1
14
2
2
26
10
1
3
1
1
6
9
10
2
4
10
20
5
97
8
3
100
7
1
8
3
1
1
6
12
2
1
11
18
8
1
4
12
1
5
4
11
43
7
2
1,108
5
25
2
73
17
10
23
12
5
1
10
17
2
30
4
9

Regions

26
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
11
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
27
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
19
21
8
7
71
55
54
54
53
52
53
102
840

Price

Date

Pages

Offers

3
4
1